SIMILAR PATTERNS OF AMINO ACIDS FOR 6D9H_R_ADNR400

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1d1t ALCOHOL
DEHYDROGENASE CLASS
IV SIGMA CHAIN

(Homo sapiens) 		PF00107
(ADH_zinc_N)
PF08240
(ADH_N) 		5 VAL A  65
PHE A  21
LEU A 372
ILE A  45
THR A  43
 None
 1.22A 6d9hR-1d1tA:
undetectable		 6d9hR-1d1tA:
12.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gh6 RETINOBLASTOMA-ASSOC
IATED PROTEIN

(Homo sapiens) 		PF01857
(RB_B)
PF01858
(RB_A) 		5 VAL B 493
THR B 497
PHE B 535
ILE B 547
THR B 543
 None
 1.41A 6d9hR-1gh6B:
undetectable		 6d9hR-1gh6B:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gq1 CYTOCHROME CD1
NITRITE REDUCTASE

(Paracoccus
pantotrophus) 		PF02239
(Cytochrom_D1)
PF13442
(Cytochrome_CBB3) 		5 VAL A 403
MET A 478
LEU A 454
ILE A 445
THR A 447
 None
 1.39A 6d9hR-1gq1A:
undetectable		 6d9hR-1gq1A:
8.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wue MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Enterococcus
faecalis) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		5 VAL A1267
LEU A1301
ASN A1302
ILE A1270
THR A1106
 None
 1.35A 6d9hR-1wueA:
undetectable		 6d9hR-1wueA:
12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xfl THIOREDOXIN H1

(Arabidopsis
thaliana) 		PF00085
(Thioredoxin) 		5 VAL A  32
PHE A  50
LEU A 105
ILE A 109
THR A 108
 None
 1.11A 6d9hR-1xflA:
undetectable		 6d9hR-1xflA:
19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dpg GLUCOSE 6-PHOSPHATE
DEHYDROGENASE

(Leuconostoc
mesenteroides) 		PF00479
(G6PD_N)
PF02781
(G6PD_C) 		5 VAL A 334
THR A 241
LEU A 233
ASN A 313
ILE A 446
 None
 1.21A 6d9hR-2dpgA:
undetectable		 6d9hR-2dpgA:
10.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fnu AMINOTRANSFERASE

(Helicobacter
pylori) 		PF01041
(DegT_DnrJ_EryC1) 		5 VAL A 365
THR A 368
GLU A 344
MET A 290
LEU A 302
 None
 1.32A 6d9hR-2fnuA:
undetectable		 6d9hR-2fnuA:
12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gq3 MALATE SYNTHASE G

(Mycobacterium
tuberculosis) 		PF01274
(Malate_synthase) 		5 VAL A 396
LEU A 335
ASN A 387
ILE A 109
THR A 267
 None
 1.41A 6d9hR-2gq3A:
undetectable		 6d9hR-2gq3A:
8.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h12 CITRATE SYNTHASE

(Acetobacter
aceti) 		PF00285
(Citrate_synt) 		5 VAL A  93
GLU A  86
LEU A 233
ILE A  81
HIS A  76
 None
 1.33A 6d9hR-2h12A:
1.2		 6d9hR-2h12A:
12.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rq7 ATP SYNTHASE EPSILON
CHAIN

(Spinacia
oleracea;
Thermosynechococcus
elongatus) 		PF00401
(ATP-synt_DE)
PF02823
(ATP-synt_DE_N) 		5 VAL A  74
GLU A  21
MET A  49
LEU A  31
THR A  42
 None
 1.46A 6d9hR-2rq7A:
undetectable		 6d9hR-2rq7A:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2uvf EXOPOLYGALACTURONASE

(Yersinia
enterocolitica) 		PF00295
(Glyco_hydro_28)
PF12708
(Pectate_lyase_3) 		5 VAL A 365
PHE A 385
LEU A 370
ASN A 396
ILE A 357
 None
 1.43A 6d9hR-2uvfA:
undetectable		 6d9hR-2uvfA:
7.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c8g PUTATIVE
TRANSCRIPTIONAL
REGULATOR

(Shigella
flexneri) 		PF05068
(MtlR) 		5 VAL B 119
MET B  23
LEU B  30
ILE B  88
THR B 163
 None
 1.40A 6d9hR-3c8gB:
2.9		 6d9hR-3c8gB:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3do5 HOMOSERINE
DEHYDROGENASE

(Archaeoglobus
fulgidus) 		PF00742
(Homoserine_dh)
PF03447
(NAD_binding_3) 		5 VAL A 110
GLU A 121
MET A 126
LEU A 118
THR A 141
 None
 1.44A 6d9hR-3do5A:
undetectable		 6d9hR-3do5A:
17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f5b AMINOGLYCOSIDE
N(6')ACETYLTRANSFERA
SE

(Legionella
pneumophila) 		PF13523
(Acetyltransf_8) 		5 VAL A  25
LEU A  43
ASN A  35
ILE A  47
THR A  46
 None
 1.22A 6d9hR-3f5bA:
undetectable		 6d9hR-3f5bA:
17.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gde DNA LIGASE

(Archaeoglobus
fulgidus) 		PF01068
(DNA_ligase_A_M)
PF04675
(DNA_ligase_A_N)
PF04679
(DNA_ligase_A_C) 		5 VAL A 117
THR A 120
PHE A  45
LEU A  59
ILE A 159
 None
 1.29A 6d9hR-3gdeA:
undetectable		 6d9hR-3gdeA:
9.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hpf MUCONATE
CYCLOISOMERASE

(Oceanobacillus
iheyensis) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		5 THR A 211
PHE A 194
LEU A 235
ILE A 243
THR A 239
 None
 1.24A 6d9hR-3hpfA:
undetectable		 6d9hR-3hpfA:
12.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i7a PUTATIVE
METAL-DEPENDENT
PHOSPHOHYDROLASE

(Shewanella
amazonensis) 		PF08668
(HDOD) 		5 VAL A  63
GLU A 100
LEU A 154
ILE A 122
THR A 125
 None
 1.38A 6d9hR-3i7aA:
undetectable		 6d9hR-3i7aA:
12.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ive NUCLEOTIDASE

(Escherichia
coli) 		PF00149
(Metallophos)
PF02872
(5_nucleotid_C) 		5 VAL A 241
THR A 237
LEU A 166
ASN A 136
ILE A 164
 None
 1.39A 6d9hR-3iveA:
undetectable		 6d9hR-3iveA:
10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qak ADENOSINE RECEPTOR
A2A,LYSOZYME CHIMERA

(Escherichia
virus T4;
Homo sapiens) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		6 VAL A  84
THR A  88
PHE A 168
GLU A 169
MET A 177
HIS A 278
 None
UKA  A1200 (-3.6A)
UKA  A1200 (-3.4A)
UKA  A1200 (-2.7A)
UKA  A1200 (-4.8A)
UKA  A1200 (-3.9A)
 0.97A 6d9hR-3qakA:
33.3		 6d9hR-3qakA:
11.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qak ADENOSINE RECEPTOR
A2A,LYSOZYME CHIMERA

(Escherichia
virus T4;
Homo sapiens) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		8 VAL A  84
THR A  88
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
HIS A 278
 None
UKA  A1200 (-3.6A)
UKA  A1200 (-3.4A)
UKA  A1200 (-4.8A)
UKA  A1200 (-4.9A)
UKA  A1200 (-3.4A)
UKA  A1200 (-4.9A)
UKA  A1200 (-3.9A)
 0.54A 6d9hR-3qakA:
33.3		 6d9hR-3qakA:
11.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3thw DNA MISMATCH REPAIR
PROTEIN MSH3

(Homo sapiens) 		PF00488
(MutS_V)
PF01624
(MutS_I)
PF05188
(MutS_II)
PF05192
(MutS_III) 		5 VAL B 822
PHE B 643
GLU B 642
LEU B 609
THR B 560
 None
 1.31A 6d9hR-3thwB:
3.0		 6d9hR-3thwB:
6.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tr1 3-PHOSPHOSHIKIMATE
1-CARBOXYVINYLTRANSF
ERASE

(Coxiella
burnetii) 		PF00275
(EPSP_synthase) 		5 VAL A 394
GLU A 316
LEU A 270
ILE A 241
THR A 245
 None
 1.14A 6d9hR-3tr1A:
undetectable		 6d9hR-3tr1A:
13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zm8 GH26
ENDO-BETA-1,4-MANNAN
ASE

(Podospora
anserina) 		PF02156
(Glyco_hydro_26)
PF16990
(CBM_35) 		5 VAL A 438
PHE A 410
LEU A 429
ASN A 424
ILE A 179
 None
 1.37A 6d9hR-3zm8A:
undetectable		 6d9hR-3zm8A:
10.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zm8 GH26
ENDO-BETA-1,4-MANNAN
ASE

(Podospora
anserina) 		PF02156
(Glyco_hydro_26)
PF16990
(CBM_35) 		5 VAL A 438
PHE A 410
LEU A 429
ILE A 179
THR A 183
 None
 1.38A 6d9hR-3zm8A:
undetectable		 6d9hR-3zm8A:
10.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bev COPPER EFFLUX ATPASE

(Legionella
pneumophila) 		PF00122
(E1-E2_ATPase)
PF00702
(Hydrolase) 		5 VAL A 425
THR A 430
LEU A 591
ILE A 563
THR A 559
 None
 1.38A 6d9hR-4bevA:
3.2		 6d9hR-4bevA:
8.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c41 CORTICOSTEROID-BINDI
NG GLOBULIN

(Homo sapiens) 		PF00079
(Serpin) 		5 PHE A  24
MET A 297
LEU A  32
ILE A  43
HIS A 325
 None
 1.26A 6d9hR-4c41A:
undetectable		 6d9hR-4c41A:
12.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gew 5'-TYROSYL-DNA
PHOSPHODIESTERASE

(Caenorhabditis
elegans) 		PF03372
(Exo_endo_phos)
PF14555
(UBA_4) 		5 VAL A 266
GLU A 256
MET A 251
LEU A 214
ILE A 216
 None
 1.50A 6d9hR-4gewA:
undetectable		 6d9hR-4gewA:
14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hhe QUINOLINATE SYNTHASE
A

(Pyrococcus
furiosus) 		PF02445
(NadA) 		5 VAL A 157
THR A 161
PHE A 147
LEU A 140
ILE A 136
 None
 1.42A 6d9hR-4hheA:
undetectable		 6d9hR-4hheA:
12.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iul EUKARYOTIC
TRANSLATION
INITIATION FACTOR 4
GAMMA 2

(Homo sapiens) 		PF02854
(MIF4G) 		5 VAL A 182
THR A 179
GLU A 249
LEU A 235
THR A 234
 None
 1.49A 6d9hR-4iulA:
2.7		 6d9hR-4iulA:
14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ixo NIFS-LIKE PROTEIN

(Rickettsia
africae) 		PF00266
(Aminotran_5) 		5 VAL A 275
PHE A 363
LEU A 265
ILE A 345
THR A 289
 None
 1.41A 6d9hR-4ixoA:
undetectable		 6d9hR-4ixoA:
11.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jmp C-TERMINAL FRAGMENT
OF CAPA, PROTEIN
TYROSINE KINASE

(Staphylococcus
aureus) 		PF01656
(CbiA) 		5 VAL A1121
THR A1114
LEU A1011
ASN A1061
ILE A1088
 None
 1.23A 6d9hR-4jmpA:
undetectable		 6d9hR-4jmpA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4leo RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3

(Homo sapiens) 		PF00757
(Furin-like)
PF01030
(Recep_L_domain)
PF14843
(GF_recep_IV) 		5 VAL C 324
THR C 315
PHE C 368
LEU C 378
ILE C 380
 None
 1.12A 6d9hR-4leoC:
undetectable		 6d9hR-4leoC:
8.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4maa PUTATIVE
BRANCHED-CHAIN AMINO
ACID ABC
TRANSPORTER,
PERIPLASMIC AMINO
ACID-BINDING PROTEIN

(Pseudomonas
protegens) 		PF13458
(Peripla_BP_6) 		5 VAL A 122
PHE A 142
LEU A 340
ILE A 317
THR A 321
 None
 1.35A 6d9hR-4maaA:
undetectable		 6d9hR-4maaA:
12.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p56 PUTATIVE
EXTRACELLULAR
SOLUTE-BINDING
PROTEIN

(Bordetella
bronchiseptica) 		PF03480
(DctP) 		5 VAL A  90
PHE A  99
GLU A 134
LEU A 140
ILE A 143
 None
PGE  A 402 ( 4.5A)
None
None
None
 1.25A 6d9hR-4p56A:
undetectable		 6d9hR-4p56A:
11.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g53 ADENOSINE RECEPTOR
A2A

(Homo sapiens) 		PF00001
(7tm_1) 		8 THR A  88
PHE A 168
GLU A 169
MET A 177
LEU A 249
ASN A 253
ILE A 274
HIS A 278
 NEC  A 400 (-3.7A)
NEC  A 400 (-3.6A)
NEC  A 400 (-4.0A)
NEC  A 400 (-4.8A)
NEC  A 400 ( 4.6A)
NEC  A 400 (-3.3A)
NEC  A 400 (-4.6A)
NEC  A 400 (-3.6A)
 0.89A 6d9hR-5g53A:
35.8		 6d9hR-5g53A:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g53 ADENOSINE RECEPTOR
A2A

(Homo sapiens) 		PF00001
(7tm_1) 		8 VAL A  84
THR A  88
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
HIS A 278
 None
NEC  A 400 (-3.7A)
NEC  A 400 (-3.6A)
NEC  A 400 (-4.8A)
NEC  A 400 ( 4.6A)
NEC  A 400 (-3.3A)
NEC  A 400 (-4.6A)
NEC  A 400 (-3.6A)
 0.45A 6d9hR-5g53A:
35.8		 6d9hR-5g53A:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5me3 SISTER CHROMATID
COHESION PROTEIN 2

(Eremothecium
gossypii) 		PF12765
(Cohesin_HEAT)
PF12830
(Nipped-B_C) 		5 VAL A1369
PHE A1324
MET A1362
LEU A1345
ILE A1341
 None
 1.29A 6d9hR-5me3A:
3.7		 6d9hR-5me3A:
7.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		5 VAL A1192
LEU A1355
ASN A1359
ILE A1379
HIS A1383
 8K8  A2001 ( 4.1A)
8K8  A2001 ( 4.3A)
8K8  A2001 ( 3.1A)
8K8  A2001 ( 4.2A)
None
 1.08A 6d9hR-5n2sA:
32.3		 6d9hR-5n2sA:
30.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		5 VAL A1192
MET A1285
LEU A1355
ASN A1359
HIS A1383
 8K8  A2001 ( 4.1A)
8K8  A2001 ( 4.5A)
8K8  A2001 ( 4.3A)
8K8  A2001 ( 3.1A)
None
 1.00A 6d9hR-5n2sA:
32.3		 6d9hR-5n2sA:
30.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		5 VAL A1192
PHE A1276
LEU A1355
ILE A1379
HIS A1383
 8K8  A2001 ( 4.1A)
8K8  A2001 ( 3.4A)
8K8  A2001 ( 4.3A)
8K8  A2001 ( 4.2A)
None
 1.07A 6d9hR-5n2sA:
32.3		 6d9hR-5n2sA:
30.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n2s SOLUBLE CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		5 VAL A1192
PHE A1276
MET A1285
LEU A1355
HIS A1383
 8K8  A2001 ( 4.1A)
8K8  A2001 ( 3.4A)
8K8  A2001 ( 4.5A)
8K8  A2001 ( 4.3A)
None
 1.13A 6d9hR-5n2sA:
32.3		 6d9hR-5n2sA:
30.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uen ADENOSINE RECEPTOR
A1,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		5 VAL A  62
LEU A 250
ILE A 274
THR A 277
HIS A 278
 None
DU1  A1201 (-4.4A)
DU1  A1201 (-4.3A)
None
None
 1.23A 6d9hR-5uenA:
32.0		 6d9hR-5uenA:
12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uen ADENOSINE RECEPTOR
A1,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		7 VAL A  87
PHE A 171
GLU A 172
MET A 180
LEU A 250
ASN A 254
HIS A 278
 DU1  A1201 (-4.7A)
DU1  A1201 (-3.5A)
DU1  A1201 (-3.6A)
DU1  A1201 (-3.4A)
DU1  A1201 (-4.4A)
DU1  A1201 (-3.1A)
None
 1.13A 6d9hR-5uenA:
32.0		 6d9hR-5uenA:
12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uen ADENOSINE RECEPTOR
A1,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		8 VAL A  87
PHE A 171
MET A 180
LEU A 250
ASN A 254
ILE A 274
THR A 277
HIS A 278
 DU1  A1201 (-4.7A)
DU1  A1201 (-3.5A)
DU1  A1201 (-3.4A)
DU1  A1201 (-4.4A)
DU1  A1201 (-3.1A)
DU1  A1201 (-4.3A)
None
None
 1.03A 6d9hR-5uenA:
32.0		 6d9hR-5uenA:
12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uen ADENOSINE RECEPTOR
A1,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		7 VAL A  87
THR A  91
PHE A 171
GLU A 172
MET A 180
LEU A 250
ASN A 254
 DU1  A1201 (-4.7A)
DU1  A1201 (-3.7A)
DU1  A1201 (-3.5A)
DU1  A1201 (-3.6A)
DU1  A1201 (-3.4A)
DU1  A1201 (-4.4A)
DU1  A1201 (-3.1A)
 1.09A 6d9hR-5uenA:
32.0		 6d9hR-5uenA:
12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uen ADENOSINE RECEPTOR
A1,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A1

(Escherichia
coli;
Homo sapiens) 		PF00001
(7tm_1)
PF07361
(Cytochrom_B562) 		8 VAL A  87
THR A  91
PHE A 171
MET A 180
LEU A 250
ASN A 254
ILE A 274
THR A 277
 DU1  A1201 (-4.7A)
DU1  A1201 (-3.7A)
DU1  A1201 (-3.5A)
DU1  A1201 (-3.4A)
DU1  A1201 (-4.4A)
DU1  A1201 (-3.1A)
DU1  A1201 (-4.3A)
None
 1.07A 6d9hR-5uenA:
32.0		 6d9hR-5uenA:
12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6aqf ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A

(Escherichia
coli;
Homo sapiens) 		no annotation 5 PHE A 168
GLU A 169
MET A 177
LEU A 249
ASN A 253
 ZMA  A1201 (-3.5A)
ZMA  A1201 (-4.1A)
None
ZMA  A1201 (-4.1A)
ZMA  A1201 (-3.2A)
 1.11A 6d9hR-6aqfA:
30.1		 6d9hR-6aqfA:
27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6aqf ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A

(Escherichia
coli;
Homo sapiens) 		no annotation 7 VAL A  84
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
HIS A 278
 None
ZMA  A1201 (-3.5A)
None
ZMA  A1201 (-4.1A)
ZMA  A1201 (-3.2A)
ZMA  A1201 (-4.8A)
None
 1.00A 6d9hR-6aqfA:
30.1		 6d9hR-6aqfA:
27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6aqf ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A

(Escherichia
coli;
Homo sapiens) 		no annotation 7 VAL A  84
THR A  88
PHE A 168
MET A 177
LEU A 249
ASN A 253
ILE A 274
 None
None
ZMA  A1201 (-3.5A)
None
ZMA  A1201 (-4.1A)
ZMA  A1201 (-3.2A)
ZMA  A1201 (-4.8A)
 1.08A 6d9hR-6aqfA:
30.1		 6d9hR-6aqfA:
27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6emk SERINE/THREONINE-PRO
TEIN KINASE TOR2

(Saccharomyces
cerevisiae) 		no annotation 5 PHE A 212
GLU A 213
LEU A 286
ASN A 266
ILE A 245
 None
 1.15A 6d9hR-6emkA:
undetectable		 6d9hR-6emkA:
23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g3d ARGININOSUCCINATE
LYASE

(Chelativorans
sp. BNC1) 		no annotation 5 LEU A 335
ASN A 245
ILE A 336
THR A 339
HIS A 340
 None
 1.25A 6d9hR-6g3dA:
3.1		 6d9hR-6g3dA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gdg TRXA,ADENOSINE
RECEPTOR A2A

(Escherichia
coli;
Homo sapiens) 		no annotation 7 VAL A  84
THR A  88
MET A 177
LEU A 249
ASN A 253
ILE A 274
HIS A 278
 None
NEC  A 400 (-3.8A)
NEC  A 400 (-4.3A)
NEC  A 400 (-4.9A)
NEC  A 400 (-3.5A)
NEC  A 400 (-4.2A)
NEC  A 400 (-3.7A)
 0.67A 6d9hR-6gdgA:
35.2		 6d9hR-6gdgA:
18.39